English press releases

Belkin UltraGlass screen protectors for the iPhone 14 lineup now available

Begins shipping worldwide today LOS ANGELES –(BUSINESS WIRE)– Belkin, a global consumer electronics leader, today introduces the Belkin UltraGlass Screen Protector engineered and designed for iPhone...

Xevinapant Five-Year Data Show Survival Rate Nearly Doubled in Patients with Unresected LA SCCHN, When Added to Standard of Care

Not intended for US-, Canada- and UK-based media First randomized trial in decades to show significant improvement in overall survival in patients with LA SCCHN,...

Merck to Highlight Data at ESMO 2022 with Potential for Transformative Impact on Cancer Patients

Not intended for US- or Canada-based media Late-breaking data highlight 5-year survival results from Phase II study of the investigational IAP inhibitor xevinapant in the...

Seagen to Highlight Research in Urothelial and Colorectal Cancers at 2022 European Society for Medical Oncology (ESMO) Congress

– Results from EV-103 trial evaluating PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) in urothelial cancer to be featured as late-breaking oral session – BOTHELL, Wash.–(BUSINESS...

ABB Shareholders Approve Accelleron Spin-off

ZURICH–(BUSINESS WIRE)– The shareholders of ABB approved the proposed spin-off of its Accelleron turbocharging division at today’s Extraordinary General Shareholders Meeting of ABB Ltd held...

Armut & ProntoPro Merge and Raise €15 Million To Be the Leading Local Services Marketplace in EMEA

Turkey’s leading local services marketplace Armut.com joins forces with Italian leading company ProntoPro and the new company raises €15 million to strengthen its leadership position...

Akulaku Establishes Partnership with Alipay+ To Make Cross-Border Shopping More Accessible for Consumers

Akulaku PayLater is the first BNPL wallet in Southeast Asia to partner with Alipay+ SINGAPORE–(BUSINESS WIRE)– Akulaku (“Akulaku” or “the Company”), a leading banking and...

IFF to Webcast Fireside Chat at Barclays Global Consumer Staples Conference on Sept. 8

NEW YORK–(BUSINESS WIRE)– IFF (NYSE: IFF) today announced that Chief Executive Officer Frank Clyburn will participate in a fireside chat at the Barclays Global Consumer...

CellPoint Digital partners with Radisson Hotel Group

The new strategic partnership will deliver a range of benefits to the Group and its customers LONDON–(BUSINESS WIRE)– CellPoint Digital, the global leader in payment...

GALDERMA Showcases Its Continued Commitment to Innovation in Dermatology With New Data to Be Presented at 2022 EADV Congress

Galderma, the pure-play dermatology category leader with a 40+ year heritage in dermatology, will present one oral, six symposia and four hub sessions demonstrating its...

New data from Boehringer Ingelheim support the potential use of nintedanib in children and adolescents with fibrosing interstitial lung disease

InPedILD Phase III trial showed encouraging results for both primary endpoints. Full data were published in the European Respiratory Journal and presented at the European...

Simpson Thacher Adds Leading Tax Practitioner in London

LONDON & NEW YORK–(BUSINESS WIRE)– Simpson Thacher & Bartlett LLP announced today that Sarah Lindley has joined the Firm as a Partner in its London...

Ant Group Makes Trusted AI Solutions More Accessible to Support Industrial Collaboration in Digital Economy

SHANGHAI, China–(BUSINESS WIRE)– Ant Group today announced three initiatives to make trusted AI more accessible. This includes making its graph processing database TuGraph open source;...

Vertex Announces U.S. FDA Approval for ORKAMBI® (lumacaftor/ivacaftor) in Children With Cystic Fibrosis Ages 12 to <24 months

-With this approval, approximately 300 children with two copies of the F508del mutation will have a medicine to treat the underlying cause of their disease...

U.S. FDA approves first treatment option for generalized pustular psoriasis flares in adults

Spesolimab is a monoclonal antibody that inhibits interleukin-36 (IL-36) signaling and is the first treatment specifically approved for the treatment of generalized pustular psoriasis flares...